#doximity

[ follow ]
#pharmaceutical-digital-marketing #stock-rating #revenue-guidance #earnings-estimates #price-target
Business
fromInvesting.com Australia
21 hours ago

Mizuho cuts Doximity stock price target on weaker growth outlook By Investing.com

Mizuho cut Doximity’s price target to $26 and kept a Neutral rating due to weaker fiscal 2027 growth guidance and reduced industry marketing spend.
fromInvesting.com South Africa
22 hours ago

Mizuho cuts Doximity stock price target on weaker growth outlook By Investing.com

Mizuho lowered its price target on Inc () to $26 from $34 on Thursday while maintaining a Neutral rating on the shares. The stock currently trades at $23.39, down 53% over the past six months and 47% year-to-date. The firm cited the company's more muted growth outlook for fiscal year 2027 as the reason for the price target reduction.
Business
Business
from24/7 Wall St.
4 months ago

Analysts See More Upside for this Rallying Cruise Stock

Jefferies upgraded Viking to buy with an $80 target, citing strong revenue, EBITDA, EPS growth and >100% free cash flow conversion.
[ Load more ]